Bison Wealth’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.02M | Sell |
20,330
-11,596
| -36% | -$1.2M | 0.45% | 51 |
|
|
2024
Q3 | $3.63M | Buy |
31,926
+6,401
| +25% | +$760K | 0.58% | 40 |
|
|
2024
Q2 | $3.37M | Hold |
25,525
| – | – | 0.55% | 42 |
|
|
2024
Q1 | $3.37M | Sell |
25,525
-235
| -0.9% | -$29K | 0.55% | 42 |
|
|
2023
Q4 | $2.81M | Buy |
25,760
+907
| +4% | +$94.1K | 0.5% | 46 |
|
|
2023
Q3 | $2.56M | Sell |
24,853
-686
| -3% | -$73.9K | 0.5% | 45 |
|
|
2023
Q2 | $2.95M | Buy |
25,539
+6,916
| +37% | +$785K | 0.55% | 42 |
|
|
2023
Q1 | $2.19M | Sell |
18,623
-280
| -1% | -$30.2K | 0.68% | 37 |
|
|
2022
Q4 | $2.01M | Buy |
18,903
+609
| +3% | +$62.3K | 0.64% | 44 |
|
|
2022
Q3 | $1.57M | Buy |
18,294
+7,292
| +66% | +$651K | 0.62% | 45 |
|
|
2022
Q2 | $1M | Buy |
11,002
+308
| +3% | +$27.3K | 0.58% | 48 |
|
|
2022
Q1 | $877K | Sell |
10,694
-331
| -3% | -$26.1K | 0.45% | 59 |
|
|
2021
Q4 | $845K | Sell |
11,025
-810
| -7% | -$64.5K | 0.49% | 52 |
|
|
2021
Q3 | $889K | Sell |
11,835
-197
| -2% | -$15K | 0.41% | 54 |
|
|
2021
Q2 | $936K | Sell |
12,032
-425
| -3% | -$31.6K | 0.41% | 59 |
|
|
2021
Q1 | $916K | Buy |
12,457
+126
| +1% | +$9.29K | 0.39% | 59 |
|
|
2020
Q4 | $962K | Buy |
12,331
+32
| +0.3% | +$2.45K | 0.45% | 50 |
|
|
2020
Q3 | $974K | Sell |
12,299
-2,885
| -19% | -$226K | 0.57% | 45 |
|
|
2020
Q2 | $1.12M | Buy |
15,184
+92
| +0.6% | +$6.93K | 0.71% | 34 |
|
|
2020
Q1 | $1.11M | Sell |
15,092
-3,430
| -19% | -$270K | 0.8% | 29 |
|
|
2019
Q4 | $1.61M | Sell |
18,522
-174
| -0.9% | -$14.3K | 0.77% | 36 |
|
|
2019
Q3 | $1.5M | Sell |
18,696
-2,172
| -10% | -$174K | 0.83% | 35 |
|
|
2019
Q2 | $1.67M | Buy |
20,868
+2,560
| +14% | +$196K | 0.97% | 26 |
|
|
2019
Q1 | $1.45M | Sell |
18,308
-880
| -5% | -$65.8K | 0.89% | 29 |
|
|
2018
Q4 | $1.4M | Buy |
19,188
+254
| +1% | +$17.9K | 1.02% | 25 |
|
|
2018
Q3 | $1.28M | Buy |
18,934
+161
| +0.9% | +$10.3K | 0.84% | 27 |
|
|
2018
Q2 | $1.09M | Buy |
18,773
+528
| +3% | +$29.8K | 0.81% | 31 |
|
|
2018
Q1 | $948K | Sell |
18,245
-370
| -2% | -$20K | 0.72% | 37 |
|
|
2017
Q4 | $999K | Sell |
18,615
-332
| -2% | -$18.4K | 0.74% | 33 |
|
|
2017
Q3 | $1.16M | Sell |
18,947
-849
| -4% | -$51.5K | 0.93% | 27 |
|
|
2017
Q2 | $1.21M | Sell |
19,796
-381
| -2% | -$23.2K | 1% | 23 |
|
|
2017
Q1 | $1.22M | Sell |
20,177
-1,431
| -7% | -$86.8K | 1.05% | 23 |
|
|
2016
Q4 | $1.21M | Sell |
21,608
-1,597
| -7% | -$93.5K | 1.03% | 25 |
|
|
2016
Q3 | $1.38M | Sell |
23,205
-140
| -0.6% | -$8.19K | 1.17% | 21 |
|
|
2016
Q2 | $1.28M | Buy |
23,345
+50
| +0.2% | +$2.66K | 0.77% | 37 |
|
|
2016
Q1 | $1.18M | Sell |
23,295
-520
| -2% | -$25.5K | 0.76% | 39 |
|
|
2015
Q4 | $1.2M | Buy |
23,815
+264
| +1% | +$13.3K | 0.68% | 40 |
|
|
2015
Q3 | $1.11M | Sell |
23,551
-8,011
| -25% | -$426K | 0.73% | 33 |
|
|
2015
Q2 | $1.72M | Buy |
31,562
+11,249
| +55% | +$631K | 1% | 22 |
|
|
2015
Q1 | $1.11M | Buy |
20,313
+2,441
| +14% | +$138K | 0.68% | 33 |
|
|
2014
Q4 | $968K | Buy |
+17,872
| New | +$996K | 0.73% | 30 |
|
Other funds holding MRK
Bison Wealth's MRK Position: Q4 2024 in Review
Bison Wealth reduced its Merck (MRK) stake by 36% in Q4 2024, selling an estimated $1.2M and leaving 20,330 shares worth $2.02M. The position accounts for 0.45% of the portfolio, ranked #51.
Bison Wealth first reported a position in MRK in Q4 2014 and has held it in 41 quarters since. The position peaked at $3.63M in Q3 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.
- Bison Wealth held 20,330 shares of Merck worth $2.02M as of Q4 2024.
- Bison Wealth sold 11,596 Merck shares in Q4 2024, an estimated $1.2M.
- Merck made up 0.45% of Bison Wealth's portfolio in Q4 2024, its #51 holding.
- Bison Wealth first reported a position in Merck in Q4 2014 and has held it in 41 quarters since.
- Bison Wealth's Merck position peaked at $3.63M in Q3 2024.
- 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.
Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.